Mechanisms of matrix metalloproteinase-9 and matrix metalloproteinase-2 inhibition by N-acetylcysteine in the human term decidua and fetal membranes

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 6, 2003, Pages 1758-1763

  Weiss, Amir ^a   Goldman, Shlomit ^a   Shlomo, Izhar Ben ^b   Eyali, Vered ^a   Leibovitz, Shamir ^c   Shalev, Eliezer ^a,b  

^a HAEMEK MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c BioTerm LTD   (Israel)

Author keywords

Fetal membrane; Matrix metalloproteinase; Matrix metalloproteinase inhibitor; N acetylcysteine; Preterm labor

Indexed keywords

ACETYLCYSTEINE; GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

AMNION; ARTICLE; CESAREAN SECTION; CHORION; CONTROLLED STUDY; CULTURE MEDIUM; DECIDUA; DRUG INHIBITION; ELECTIVE SURGERY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME RELEASE; FEMALE; FETUS MEMBRANE; HUMAN; HUMAN TISSUE; INCUBATION TIME; ORGAN CULTURE; PREMATURE LABOR; PRIORITY JOURNAL; STUDENT T TEST; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 0346727261     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(03)00847-0     Document Type: Article

References (23)

1. Goldenberg RL, Rouse DJ. The prevention of premature birth. N Engl J Med 1998;339:313-20.
2. Goldenberg RL, Jobe AH. Prospects for research in reproductive health and birth outcomes. JAMA 2001;285:633-9.
3. Parry S, Strauss JF. Premature rupture of the fetal membranes. N Engl J Med 1998;338:663-70.
4. Fortunato SJ, Menon R, Lombardi SJ. Presence of four inhibitors of matrix metalloproteinases (TIMP-1, -2, -3, and -4) in human fetal membranes. Am J Reprod Immunol 1998;40:395-400.
5. Vadillo-Ortega F, Gonzalles-Avila G, Furth EE, Lei H, Musche RJ, Stetler-Stevenson WG, et al. 92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am J Pathol 1995;146:148-56.
6. Bryant-Greenwood GD, Yamamoto SY. Control of peripartal collagenolysis in the human chorion-decidua. Am J Obstet Gynecol 1995;172:63-70.
7. Athayde N, Edwin SS, Romero R, Gomez R, Maymon E, Pacora P, et al. A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol 1998;179:1248-53.
8. Fortunato SJ, Menon R, Lombardi SJ. Collagenolytic enzymes (gelatinases) and their inhibitors in human amniochorionic membranes. Am J Obstet Gynecol 1997;177:731-7.
9. Locksmith GJ, Clark P, Duff P, Saade GR, Schultz GS. Amniotic fluid concentrations of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during pregnancy and labor. Am J Obstet Gynecol 2001;184:159-64.
10. Fortunato SJ, Menon R. Distinct molecular events suggest different pathways for preterm labor and premature rupture of the membranes. Am J Obstet Gynecol 2001;184:1399-406.
11. Maymon E, Romero R, Pacora P, Gervasi MT, Gomez R, Edwin SS, et al. Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-amniotic infection. Am J Obstet Gynecol 2000;183:887-94.
12. Maymon E, Romero R, Pacora P, Gomez R, Athayde N, Edwin S, et al. Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection. Am J Obstet Gynecol 2000;183:94-9.
13. Vadillo-Ortega F, Hernandez A, Gonzalles-Avila G, Bermejo L, Iwata K, Strauss JF 3rd. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of the membranes. Am J Obstet Gynecol 1996;174:1371-6.
14. Riley SC, Leask R, Denison FC, Wisely K, Calder AA, Howe DC. Secretion of tissue inhibitors of matrix metalloproteinases by human fetal membranes, decidua, and placenta at parturition. J Endocrinol 1999;162:351-9.
15. Uchide K, Ueno H, Inoue M, Sakai A, Fujimoto N, Okada Y. Matrix metalloproteinase-9 and tensile strength of fetal membranes in uncomplicated labor. Obstet Gynecol 2000;95:851-5.
16. Xu P, Alfaidy N, Challis JR. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. J Clin Endocrinol Metab 2002;87:1353-61.
17. Buhimschi IA, Kramer WB, Buhimschi CS, Thompson LP, Weiner CP. Reduction-oxidation (redox) state regulation of matrix metalloproteinase activity in human fetal membranes. Am J Obstet Gynecol 2000;182:458-64.
18. Hidalgo M, Eckhardt SG. Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 2001;93:178-93.
19. Galis ZS, Asanuma K, Godin D, Meng X. N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells. Circulation 1998;97:2445-53.
20. Kawakami S, Kageyama Y, Fujii Y, Kihara K, Oshima H. Inhibitory effect of N-acetylcysteine on invasion and MMP-9 production of T24 human bladder cancer cells. Anticancer Res 2001;21:213-20.
21. Ulug U, Goldman S, Ben-Shlomo I, Shalev E. Matrix metalloproteinases 2 and 9 and their tissue inhibitor-1 in human term decidua and fetal membranes: the effect of PGF2α and indomethacin. Mol Hum Reprod 2001;7:1187-93.
22. Albini A, D'Agostini F, Giunciugliu D, Paglieri I, Balansky R, De Flora S. Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine. Int J Cancer 1995;61:121-9.
23. Buhimschi IA, Buhimschi CS, Weiner CP. Protective effect of N-acetylcysteine against fetal death and preterm labor induced by maternal inflammation. Am J Obstet Gynecol 2003;188:203-8.